Reuters logo
BRIEF-Acentrus Specialty Signs New Agreement With Pfizer Oncology
December 4, 2017 / 4:12 PM / 10 days ago

BRIEF-Acentrus Specialty Signs New Agreement With Pfizer Oncology

Pfizer Inc:

* ACENTRUS SPECIALTY SIGNS NEW AGREEMENT WITH PFIZER ONCOLOGY

* ACENTRUS SPECIALTY SAYS SIGNED NEW AGREEMENT THAT OFFERS QUALIFIED ACENTRUS HOSPITAL AND HEALTH SYSTEM CLIENTS ACCESS TO PFIZER ONCOLOGY PRODUCTS

* ACENTRUS SPECIALTY - CONTRACT INCLUDES 5 ORAL ONCOLYTIC PRODUCTS; IBRANCE, BOSULIF , SUTENT , INLYTA AND XALKORI​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below